Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A review of major causative genes in congenital myopathies. | J Hum Genet | 2023 | 35668205 | PubTator, text mining | PubMed |
| Infant-Type Hemispheric Glioma in a Chinese Girl: A Newly Defined Entity. | Fetal Pediatr Pathol | 2023 | 35404193 | PubTator, text mining | PubMed |
| RNA-seq analysis identifies differentially expressed gene in different types of donkey skeletal muscles. | Anim Biotechnol | 2023 | 35302433 | PubTator, text mining | PubMed |
| Interlaboratory Comparison Study (Ring Test) of Next-Generation Sequencing-Based NTRK Fusion Detection in South Korea. | Cancer Res Treat | 2023 | 35167738 | PubTator, text mining | PubMed |
| Extracellular vesicles and lipoproteins - Smart messengers of blood cells in the circulation. | J Extracell Biol | 2022 | 38938581 | PubTator, text mining | PubMed |
| Proteomics research of SARS-CoV-2 and COVID-19 disease. | Med Rev (2021) | 2022 | 37724330 | PubTator, text mining | PubMed |
| The Role of Acrolein in Neurodegenerative Diseases and Its Protective Strategy. | Foods | 2022 | 37430952 | PubTator, text mining | PubMed |
| Pediatric Nemaline Myopathy: A Systematic Review Using Individual Patient Data. | J Child Neurol | 2022 | 36960434 | PubTator, text mining | PubMed |
| Angiogenesis-related gene signatures reveal the prognosis of cervical cancer based on single cell sequencing and co-expression network analysis. | Front Cell Dev Biol | 2022 | 36712973 | PubTator, text mining | PubMed |
| Case report: Acquired neurotrophic tyrosine receptor kinase inhibitor resistance in a patient with pancreatic neuroendocrine carcinoma receiving entrectinib. | Front Oncol | 2022 | 36703785 | PubTator, text mining | PubMed |
| Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy. | Front Immunol | 2022 | 36700211 | PubTator, text mining | PubMed |
| Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer. | Front Genet | 2022 | 36685937 | PubTator, text mining | PubMed |
| A microarray data analysis investigating the pathogenesis and potential biomarkers of autophagy and ferroptosis in intervertebral disc degeneration. | Front Genet | 2022 | 36685932 | PubTator, text mining | PubMed |
| Molecular Characterization of Tropomyosin and Its Potential Involvement in Muscle Contraction in Pacific Abalone. | Genes (Basel) | 2022 | 36672743 | PubTator, text mining | PubMed |
| Ensartinib in advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, two-staged, phase 1 trial. | J Thorac Dis | 2022 | 36647478 | PubTator, text mining | PubMed |
| What's new in the WHO 2022 classification of kidney tumours? | Pathologica | 2022 | 36645398 | PubTator, text mining | PubMed |
| Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas. | Transl Lung Cancer Res | 2022 | 36636421 | PubTator, text mining | PubMed |
| From targeted therapy to a novel way: Immunogenic cell death in lung cancer. | Front Med (Lausanne) | 2022 | 36619616 | PubTator, text mining | PubMed |
| Allosteric Modulators of Dopamine D2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis. | Molecules | 2022 | 36615372 | PubTator, text mining | PubMed |
| Functional Heterodimerization between the G Protein-Coupled Receptor GPR17 and the Chemokine Receptors 2 and 4: New Evidence. | Int J Mol Sci | 2022 | 36613703 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=26